A gene for a myosin peptide is disrupted by the inv(16)(p13q22) in acute nonlymphocytic leukemia M4Eo

Blood. 1993 Nov 15;82(10):2948-52.

Abstract

Chromosome 16 aberrations are well known in acute nonlymphocytic leukemia (ANLL). The most frequent chromosome 16 aberration in ANLL subtype M4Eo is the inv(16)(p13q22). Recently, we showed that in 5 inv(16) patients with ANLL M4Eo the short arm breakpoints are clustered within a 14-kb genomic EcoRI fragment. We report here the identification of a gene situated in the 14-kb fragment. The gene, which codes for a myosin peptide, is disrupted by the inversion of chromosome 16 in the 5 patients. To the best of our knowledge, this is the first report of a myosin gene disrupted in leukemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Chromosome Inversion*
  • Chromosomes, Human, Pair 16*
  • Conserved Sequence
  • DNA, Complementary / chemistry
  • Humans
  • Leukemia, Myeloid, Acute / genetics*
  • Molecular Sequence Data
  • Myosins / genetics*

Substances

  • DNA, Complementary
  • Myosins